ロード中...
Pathological response of salivary duct carcinoma to trastuzumab and docetaxel therapy
Salivary duct carcinoma (SDC) has a poor prognosis owing to the high incidence of distant metastasis. Approximately 40 % of SDCs are positive for human epidermal growth factor receptor 2 (HER2), suggesting that anti-HER2 therapy for cases with distant metastasis may be effective. However, the pathol...
保存先:
| 出版年: | Int Cancer Conf J |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Japan
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498293/ https://ncbi.nlm.nih.gov/pubmed/31149444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-016-0247-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|